PGNY News and Press, Progyny Inc. From 11/06/25

2025-11-06 16:02:18 ET More on Progyny Progyny's Strong Fundamentals And Global Growth: Why I Choose To Buy Progyny Q3 2025 Earnings Preview Progyny seesaws amid confusion over impact from Trump’s IVF initiative Seeking Alpha’s Quant Rating on P...

Reports Revenue of $313.3 Million, Reflecting 9.3% Growth Raises Full Year Guidance to Reflect Continued Strength in Member Engagement Selling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing Base Record $156.0 Million in Operating Cash Flow Generate...

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025. Th...

2025-10-22 16:55:00 ET In this podcast, Motley Fool analysts Karl Thiel, Rick Munarriz, and Tim Beyers: To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . When you're ready to invest, check out this top 10 list of stocks to buy . A ...

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs for global employers, available starting January 1, 2026. Thes...

2025-10-17 13:11:40 ET More on Progyny Progyny's Strong Fundamentals And Global Growth: Why I Choose To Buy Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript Progyny gains as White House reportedly eyeing proposal to make IVF more accessible Progyny raise...

2025-10-16 13:49:03 ET More on Progyny Progyny's Strong Fundamentals And Global Growth: Why I Choose To Buy Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accel...

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a Champion for Women’s Health by the World Economic ...

2025-09-09 08:34:43 ET Progyny (NASDAQ: PGNY ) stock is having a good year so far enjoying double-digit gains since Dec 31. The stock is trading way above its 52-week range of around $13-$26 at $22. However, for the past month the stock has been showing some weaknesses after experie...